您的位置: 首页 > 农业专利 > 详情页

SELS DE CITRATE D'UN INHIBITEUR DE KINASE DE JANUS (JAK)
专利权人:
SANDOZ AG
发明人:
申请号:
EP16201249.6
公开号:
EP3327020A1
申请日:
2016.11.29
申请国别(地区):
EP
年份:
2018
代理人:
摘要:
The present invention relates to citrate salts of baricitinib, in particular to baricitinib mono- and dicitrate, as well as to crystalline and amorphous forms thereof, and to methods for their preparation. Furthermore, the invention relates to a pharmaceutical composition comprising an effective and/or predetermined amount of one or more citrate salts of baricitinib and to the use of said pharmaceutical composition as a medicament, in particular for the treatment of rheumatoid arthritis.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充